Friday 17 November 2017
Contact US    |    Archive
PR
1 months ago

GSK s Shingrix Containing Agenus QS-21 Stimulon® Adjuvant Receives Marketing Authorization from Health Canada

LEXINGTON, Mass., Oct. 13, 2017 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology compa

Read on the original site


Hashtags:   

GSK

 | 

Shingrix

 | 

Containing

 | 

Agenus

 | 

Stimulon®

 | 

Adjuvant

 | 

Receives

 | 

Marketing

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Categories - Countries
All News
All Countries